A meta-analysis comparing the efficacy and safety of gemcitabine plus cisplatin induction chemotherapy in patients with locoregionally advanced NPC
Crossref DOI link: https://doi.org/10.1007/s00405-021-07033-8
Published Online: 2021-08-19
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiao, Lifeng
Kang, Wenyi
Liao, Jiayu
Li, Yuru https://orcid.org/0000-0002-4568-6144
Text and Data Mining valid from 2021-08-19
Version of Record valid from 2021-08-19
Article History
Received: 24 March 2021
Accepted: 4 August 2021
First Online: 19 August 2021
Declarations
:
: All the authors declare that they have no conflict of interest.
: Not applicable.